BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wagner KD, Cherfils-Vicini J, Hosen N, Hohenstein P, Gilson E, Hastie ND, Michiels JF, Wagner N. The Wilms’ tumour suppressor Wt1 is a major regulator of tumour angiogenesis and progression. Nat Commun. 2014;5:5852. [PMID: 25510679 DOI: 10.1038/ncomms6852] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 6.1] [Reference Citation Analysis]
Number Citing Articles
1 Ghazaey Zidanloo S, Hosseinzadeh Colagar A, Ayatollahi H, Bagheryan Z. G-quadruplex forming region within WT1 promoter is selectively targeted by daunorubicin and mitoxantrone: A possible mechanism for anti-leukemic effect of drugs. J Biosci 2019;44. [DOI: 10.1007/s12038-018-9837-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.3] [Reference Citation Analysis]
2 Nikas IP, Themistocleous SC, Paschou SA, Tsamis KI, Ryu HS. Serine-Arginine Protein Kinase 1 (SRPK1) as a Prognostic Factor and Potential Therapeutic Target in Cancer: Current Evidence and Future Perspectives. Cells 2019;9:E19. [PMID: 31861708 DOI: 10.3390/cells9010019] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
3 Wagner N, Ninkov M, Vukolic A, Cubukcuoglu Deniz G, Rassoulzadegan M, Michiels JF, Wagner KD. Implications of the Wilms' Tumor Suppressor Wt1 in Cardiomyocyte Differentiation. Int J Mol Sci 2021;22:4346. [PMID: 33919406 DOI: 10.3390/ijms22094346] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
4 Ghanbarian H, Wagner N, Polo B, Baudouy D, Kiani J, Michiels JF, Cuzin F, Rassoulzadegan M, Wagner KD. Dnmt2/Trdmt1 as Mediator of RNA Polymerase II Transcriptional Activity in Cardiac Growth. PLoS One 2016;11:e0156953. [PMID: 27270731 DOI: 10.1371/journal.pone.0156953] [Cited by in Crossref: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.8] [Reference Citation Analysis]
5 Baudouy D, Michiels JF, Vukolic A, Wagner KD, Wagner N. Echocardiographic and Histological Examination of Cardiac Morphology in the Mouse. J Vis Exp 2017. [PMID: 29155760 DOI: 10.3791/55843] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
6 Belali T, Wodi C, Clark B, Cheung MK, Craig TJ, Wheway G, Wagner N, Wagner KD, Roberts S, Porazinski S, Ladomery M. WT1 activates transcription of the splice factor kinase SRPK1 gene in PC3 and K562 cancer cells in the absence of corepressor BASP1. Biochim Biophys Acta Gene Regul Mech 2020;1863:194642. [PMID: 33017668 DOI: 10.1016/j.bbagrm.2020.194642] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Salvatorelli L, Calabrese G, Parenti R, Vecchio GM, Puzzo L, Caltabiano R, Musumeci G, Magro G. Immunohistochemical Expression of Wilms’ Tumor 1 Protein in Human Tissues: From Ontogenesis to Neoplastic Tissues. Applied Sciences 2020;10:40. [DOI: 10.3390/app10010040] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Duim SN, Smits AM, Kruithof BP, Goumans MJ. The roadmap of WT1 protein expression in the human fetal heart. J Mol Cell Cardiol 2016;90:139-45. [PMID: 26686990 DOI: 10.1016/j.yjmcc.2015.12.008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 1.6] [Reference Citation Analysis]
9 Du S, Wagner N, Wagner KD. The Emerging Role of PPAR Beta/Delta in Tumor Angiogenesis. PPAR Res 2020;2020:3608315. [PMID: 32855630 DOI: 10.1155/2020/3608315] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Xiong YX, Chen AC, Yao PF, Zeng DY, Lu YJ, Tan JH, Huang ZS, Ou TM. Blocking the binding of WT1 to bcl-2 promoter by G-quadruplex ligand SYUIQ-FM05. Biochem Biophys Rep 2016;5:346-52. [PMID: 28955841 DOI: 10.1016/j.bbrep.2015.12.014] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
11 Tarhriz V, Wagner KD, Masoumi Z, Molavi O, Hejazi MS, Ghanbarian H. CDK9 Regulates Apoptosis of Myoblast Cells by Modulation of microRNA-1 Expression. J Cell Biochem 2018;119:547-54. [PMID: 28608935 DOI: 10.1002/jcb.26213] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
12 Wagner N, Wagner KD. PPAR Beta/Delta and the Hallmarks of Cancer. Cells 2020;9:E1133. [PMID: 32375405 DOI: 10.3390/cells9051133] [Cited by in Crossref: 20] [Cited by in F6Publishing: 21] [Article Influence: 10.0] [Reference Citation Analysis]
13 Artibani M, Sims AH, Slight J, Aitken S, Thornburn A, Muir M, Brunton VG, Del-Pozo J, Morrison LR, Katz E, Hastie ND, Hohenstein P. WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel. Sci Rep 2017;7:45255. [PMID: 28345629 DOI: 10.1038/srep45255] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.8] [Reference Citation Analysis]
14 Gupta AK, Jadhav SH, Tripathy NK, Nityanand S. Fetal kidney stem cells ameliorate cisplatin induced acute renal failure and promote renal angiogenesis. World J Stem Cells 2015; 7(4): 776-788 [PMID: 26029348 DOI: 10.4252/wjsc.v7.i4.776] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
15 Nishida S, Tsuboi A, Tanemura A, Ito T, Nakajima H, Shirakata T, Morimoto S, Fujiki F, Hosen N, Oji Y, Kumanogoh A, Kawase I, Oka Y, Azuma I, Morita S, Sugiyama H. Immune adjuvant therapy using Bacillus Calmette-Guérin cell wall skeleton (BCG-CWS) in advanced malignancies: A phase 1 study of safety and immunogenicity assessments. Medicine (Baltimore) 2019;98:e16771. [PMID: 31415377 DOI: 10.1097/MD.0000000000016771] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 2.3] [Reference Citation Analysis]
16 Bharathavikru R, Dudnakova T, Aitken S, Slight J, Artibani M, Hohenstein P, Tollervey D, Hastie N. Transcription factor Wilms' tumor 1 regulates developmental RNAs through 3' UTR interaction. Genes Dev 2017;31:347-52. [PMID: 28289143 DOI: 10.1101/gad.291500.116] [Cited by in Crossref: 28] [Cited by in F6Publishing: 22] [Article Influence: 5.6] [Reference Citation Analysis]
17 Singh A, Ramesh S, Cibi DM, Yun LS, Li J, Li L, Manderfield LJ, Olson EN, Epstein JA, Singh MK. Hippo Signaling Mediators Yap and Taz Are Required in the Epicardium for Coronary Vasculature Development. Cell Rep 2016;15:1384-93. [PMID: 27160901 DOI: 10.1016/j.celrep.2016.04.027] [Cited by in Crossref: 72] [Cited by in F6Publishing: 68] [Article Influence: 12.0] [Reference Citation Analysis]
18 Koido S, Okamoto M, Shimodaira S, Sugiyama H. Wilms’ tumor 1 (WT1)-targeted cancer vaccines to extend survival for patients with pancreatic cancer. Immunotherapy 2016;8:1309-20. [DOI: 10.2217/imt-2016-0031] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
19 Oji Y, Hashimoto N, Tsuboi A, Murakami Y, Iwai M, Kagawa N, Chiba Y, Izumoto S, Elisseeva O, Ichinohasama R, Sakamoto J, Morita S, Nakajima H, Takashima S, Nakae Y, Nakata J, Kawakami M, Nishida S, Hosen N, Fujiki F, Morimoto S, Adachi M, Iwamoto M, Oka Y, Yoshimine T, Sugiyama H. Association of WT1 IgG antibody against WT1 peptide with prolonged survival in glioblastoma multiforme patients vaccinated with WT1 peptide. Int J Cancer 2016;139:1391-401. [PMID: 27170523 DOI: 10.1002/ijc.30182] [Cited by in Crossref: 19] [Cited by in F6Publishing: 21] [Article Influence: 3.2] [Reference Citation Analysis]
20 Wagner KD, Du S, Martin L, Leccia N, Michiels JF, Wagner N. Vascular PPARβ/δ Promotes Tumor Angiogenesis and Progression. Cells 2019;8:E1623. [PMID: 31842402 DOI: 10.3390/cells8121623] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 3.3] [Reference Citation Analysis]
21 Niderla-Bielińska J, Bartkowiak K, Ciszek B, Jankowska-Steifer E, Krejner A, Ratajska A. Sulodexide inhibits angiogenesis via decreasing Dll4 and Notch1 expression in mouse proepicardial explant cultures. Fundam Clin Pharmacol 2019;33:159-69. [PMID: 30246884 DOI: 10.1111/fcp.12418] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
22 Wagner N, Wagner KD. Every Beat You Take-The Wilms' Tumor Suppressor WT1 and the Heart. Int J Mol Sci 2021;22:7675. [PMID: 34299295 DOI: 10.3390/ijms22147675] [Reference Citation Analysis]
23 Esposito CL, Nuzzo S, Catuogno S, Romano S, de Nigris F, de Franciscis V. STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma. Mol Ther Nucleic Acids 2018;10:398-411. [PMID: 29499951 DOI: 10.1016/j.omtn.2017.12.021] [Cited by in Crossref: 47] [Cited by in F6Publishing: 44] [Article Influence: 9.4] [Reference Citation Analysis]
24 Takizawa N, Tanaka S, Oe S, Koike T, Yoshida T, Hirahara Y, Matsuda T, Yamada H. Involvement of DHH and GLI1 in adrenocortical autograft regeneration in rats. Sci Rep 2018;8:14542. [PMID: 30266964 DOI: 10.1038/s41598-018-32870-9] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
25 Hu J, Jin LU, He T, Li Y, Zhao Y, Ding YU, Li X, Liu Y, Gui Y, Mao X, Lai Y, Ni L. Wilms' tumor in a 51-year-old patient: An extremely rare case and review of the literature. Mol Clin Oncol 2016;4:1013-6. [PMID: 27313862 DOI: 10.3892/mco.2016.839] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Vanni I, Tanda ET, Dalmasso B, Pastorino L, Andreotti V, Bruno W, Boutros A, Spagnolo F, Ghiorzo P. Non-BRAF Mutant Melanoma: Molecular Features and Therapeutical Implications. Front Mol Biosci 2020;7:172. [PMID: 32850962 DOI: 10.3389/fmolb.2020.00172] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
27 Hastie ND. Wilms' tumour 1 (WT1) in development, homeostasis and disease. Development 2017;144:2862-72. [PMID: 28811308 DOI: 10.1242/dev.153163] [Cited by in Crossref: 74] [Cited by in F6Publishing: 59] [Article Influence: 14.8] [Reference Citation Analysis]
28 Wagner KD, El Maï M, Ladomery M, Belali T, Leccia N, Michiels JF, Wagner N. Altered VEGF Splicing Isoform Balance in Tumor Endothelium Involves Activation of Splicing Factors Srpk1 and Srsf1 by the Wilms' Tumor Suppressor Wt1. Cells 2019;8:E41. [PMID: 30641926 DOI: 10.3390/cells8010041] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
29 Kanai T, Ito Z, Oji Y, Suka M, Nishida S, Takakura K, Kajihara M, Saruta M, Fujioka S, Misawa T, Akiba T, Yanagisawa H, Shimodaira S, Okamoto M, Sugiyama H, Koido S. Prognostic significance of Wilms' tumor 1 expression in patients with pancreatic ductal adenocarcinoma. Oncol Lett 2018;16:2682-92. [PMID: 30008944 DOI: 10.3892/ol.2018.8961] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
30 Parenti R, Salvatorelli L, Musumeci G, Parenti C, Giorlandino A, Motta F, Magro G. Wilms’ tumor 1 (WT1) protein expression in human developing tissues. Acta Histochemica 2015;117:386-96. [DOI: 10.1016/j.acthis.2015.03.009] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 2.9] [Reference Citation Analysis]
31 Duim SN, Goumans M, Kruithof BPT; Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands, Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands, Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands. WT1 in Cardiac Development and Disease. In: van den Heuvel-eibrink MM, editor. Wilms Tumor. Codon Publications; 2016. pp. 211-33. [DOI: 10.15586/codon.wt.2016.ch13] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
32 Lv L, Chen G, Zhou J, Li J, Gong J. WT1-AS promotes cell apoptosis in hepatocellular carcinoma through down-regulating of WT1. J Exp Clin Cancer Res. 2015;34:119. [PMID: 26462627 DOI: 10.1186/s13046-015-0233-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 29] [Article Influence: 4.0] [Reference Citation Analysis]
33 Hanada S, Tsuruta T, Haraguchi K, Okamoto M, Sugiyama H, Koido S. Long-term survival of pancreatic cancer patients treated with multimodal therapy combined with WT1-targeted dendritic cell vaccines. Hum Vaccin Immunother 2019;15:397-406. [PMID: 30230959 DOI: 10.1080/21645515.2018.1524238] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
34 Kaverina NV, Eng DG, Largent AD, Daehn I, Chang A, Gross KW, Pippin JW, Hohenstein P, Shankland SJ. WT1 Is Necessary for the Proliferation and Migration of Cells of Renin Lineage Following Kidney Podocyte Depletion. Stem Cell Reports 2017;9:1152-66. [PMID: 28966119 DOI: 10.1016/j.stemcr.2017.08.020] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
35 Schmidt V, Sieckmann T, Kirschner KM, Scholz H. WT1 regulates HOXB9 gene expression in a bidirectional way. Biochim Biophys Acta Gene Regul Mech 2021;1864:194764. [PMID: 34508900 DOI: 10.1016/j.bbagrm.2021.194764] [Reference Citation Analysis]
36 Mazzei L, Sanz R, Manucha W. Alterations on a key nephrogenic/cardiogenic gene expression linked to hypertension development. Clin Investig Arterioscler 2020;32:70-8. [PMID: 31472952 DOI: 10.1016/j.arteri.2019.06.001] [Reference Citation Analysis]
37 Akbari M, Shanley DP, Bohr VA, Rasmussen LJ. Cytosolic Self-DNA—A Potential Source of Chronic Inflammation in Aging. Cells 2021;10:3544. [DOI: 10.3390/cells10123544] [Reference Citation Analysis]
38 Krivtsova O, Makarova A, Lazarevich N. Aberrant expression of alternative isoforms of transcription factors in hepatocellular carcinoma. World J Hepatol 2018; 10(10): 645-661 [PMID: 30386458 DOI: 10.4254/wjh.v10.i10.645] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
39 Fukuda K, Funakoshi T, Sakurai T, Nakamura Y, Mori M, Tanese K, Tanikawa A, Taguchi J, Fujita T, Okamoto M, Amagai M, Kawakami Y. Peptide-pulsed dendritic cell vaccine in combination with carboplatin and paclitaxel chemotherapy for stage IV melanoma. Melanoma Res 2017;27:326-34. [PMID: 28263240 DOI: 10.1097/CMR.0000000000000342] [Cited by in Crossref: 14] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]
40 McGregor RJ, Chau YY, Kendall TJ, Artibani M, Hastie N, Hadoke PWF. WT1 expression in vessels varies with histopathological grade in tumour-bearing and control tissue from patients with breast cancer. Br J Cancer 2018;119:1508-17. [PMID: 30374123 DOI: 10.1038/s41416-018-0317-1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
41 Sanchez-Gurmaches J, Hung CM, Guertin DA. Emerging Complexities in Adipocyte Origins and Identity. Trends Cell Biol 2016;26:313-26. [PMID: 26874575 DOI: 10.1016/j.tcb.2016.01.004] [Cited by in Crossref: 125] [Cited by in F6Publishing: 113] [Article Influence: 20.8] [Reference Citation Analysis]
42 Cherfils-Vicini J, Iltis C, Cervera L, Pisano S, Croce O, Sadouni N, Győrffy B, Collet R, Renault VM, Rey-Millet M, Leonetti C, Zizza P, Allain F, Ghiringhelli F, Soubeiran N, Shkreli M, Vivier E, Biroccio A, Gilson E. Cancer cells induce immune escape via glycocalyx changes controlled by the telomeric protein TRF2. EMBO J 2019;38:e100012. [PMID: 31000523 DOI: 10.15252/embj.2018100012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 28] [Article Influence: 9.0] [Reference Citation Analysis]
43 McGregor RJ, Ogley R, Hadoke P, Hastie N. In Vivo Assays for Assessing the Role of the Wilms' Tumor Suppressor 1 (Wt1) in Angiogenesis. Methods Mol Biol 2016;1467:93-104. [PMID: 27417962 DOI: 10.1007/978-1-4939-4023-3_8] [Reference Citation Analysis]
44 Xu W, Luo F, Sun B, Ye H, Li J, Shi L, Liu Y, Lu X, Wang B, Wang Q, Liu Q, Zhang A. HIF-2α, acting via miR-191, is involved in angiogenesis and metastasis of arsenite-transformed HBE cells. Toxicol Res (Camb) 2016;5:66-78. [PMID: 30090327 DOI: 10.1039/c5tx00225g] [Cited by in Crossref: 12] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
45 Cano E, Carmona R, Ruiz-Villalba A, Rojas A, Chau YY, Wagner KD, Wagner N, Hastie ND, Muñoz-Chápuli R, Pérez-Pomares JM. Extracardiac septum transversum/proepicardial endothelial cells pattern embryonic coronary arterio-venous connections. Proc Natl Acad Sci U S A 2016;113:656-61. [PMID: 26739565 DOI: 10.1073/pnas.1509834113] [Cited by in Crossref: 68] [Cited by in F6Publishing: 60] [Article Influence: 11.3] [Reference Citation Analysis]